{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T05:57:16Z","timestamp":1769839036131,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100012462","name":"Office of Academic Affiliations, Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012462","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s10067-024-07078-0","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T08:02:33Z","timestamp":1725523353000},"page":"3409-3417","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical features, imaging use, and management in giant cell arteritis: a retrospective single-center study"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9135-2460","authenticated-orcid":false,"given":"Aradhna","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reid","family":"Weisberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiby","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Reimold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1979-2727","authenticated-orcid":false,"given":"Kyawt","family":"Shwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"issue":"15","key":"7078_CR1","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1056\/NEJMc1711031","volume":"377","author":"JH Stone","year":"2017","unstructured":"Stone JH, Klearman M, Collinson N (2017) Trial of tocilizumab in giant-cell arteritis. N Engl J Med 377(15):1494\u20131495. https:\/\/doi.org\/10.1056\/NEJMc1711031. (10 12)","journal-title":"N Engl J Med"},{"issue":"90","key":"7078_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta20900","volume":"20","author":"R Luqmani","year":"2016","unstructured":"Luqmani R, Lee E, Singh S et al (2016) The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study. Health Technol Assess 20(90):1\u2013238. https:\/\/doi.org\/10.3310\/hta20900","journal-title":"Health Technol Assess"},{"issue":"Suppl 3","key":"7078_CR3","doi-asserted-by":"publisher","first-page":"iii5","DOI":"10.1093\/rheumatology\/kez553","volume":"59","author":"C Ponte","year":"2020","unstructured":"Ponte C, Martins-Martinho J, Luqmani RA (2020) Diagnosis of giant cell arteritis. Rheumatology (Oxford) 59(Suppl 3):iii5\u2013iii16. https:\/\/doi.org\/10.1093\/rheumatology\/kez553. (05 01)","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"7078_CR4","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1093\/rheumatology\/kez385","volume":"59","author":"E Rubenstein","year":"2020","unstructured":"Rubenstein E, Maldini C, Gonzalez-Chiappe S, Chevret S, Mahr A (2020) Sensitivity of temporal artery biopsy in the diagnosis of giant cell arteritis: a systematic literature review and meta-analysis. Rheumatology (Oxford) 59(5):1011\u20131020. https:\/\/doi.org\/10.1093\/rheumatology\/kez385","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"7078_CR5","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/art.41774","volume":"73","author":"M Maz","year":"2021","unstructured":"Maz M, Chung SA, Abril A et al (2021) 2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of giant cell arteritis and takayasu arteritis. Arthritis Rheumatol 73(8):1349\u20131365. https:\/\/doi.org\/10.1002\/art.41774. (08)","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"7078_CR6","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/annrheumdis-2017-212649","volume":"77","author":"C Dejaco","year":"2018","unstructured":"Dejaco C, Ramiro S, Duftner C et al (2018) EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis 77(5):636\u2013643. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212649. (05)","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"7078_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.autrev.2018.07.012","volume":"18","author":"M Rinagel","year":"2019","unstructured":"Rinagel M, Chatelus E, Jousse-Joulin S et al (2019) Diagnostic performance of temporal artery ultrasound for the diagnosis of giant cell arteritis: a systematic review and meta-analysis of the literature. Autoimmun Rev 18(1):56\u201361. https:\/\/doi.org\/10.1016\/j.autrev.2018.07.012","journal-title":"Autoimmun Rev"},{"issue":"22","key":"7078_CR8","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1001\/jama.2016.5444","volume":"315","author":"F Buttgereit","year":"2016","unstructured":"Buttgereit F, Dejaco C, Matteson EL, Dasgupta B (2016) Polymyalgia rheumatica and giant cell arteritis: a systematic review. JAMA 315(22):2442\u20132458. https:\/\/doi.org\/10.1001\/jama.2016.5444","journal-title":"JAMA"},{"issue":"10","key":"7078_CR9","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nrrheum.2017.142","volume":"13","author":"C Dejaco","year":"2017","unstructured":"Dejaco C, Brouwer E, Mason JC, Buttgereit F, Matteson EL, Dasgupta B (2017) Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities. Nat Rev Rheumatol 13(10):578\u2013592. https:\/\/doi.org\/10.1038\/nrrheum.2017.142","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"7078_CR10","doi-asserted-by":"publisher","first-page":"366","DOI":"10.5414\/cp203901","volume":"59","author":"GG Song","year":"2021","unstructured":"Song GG, Lee YH (2021) Methotrexate for treating polymyalgia rheumatica: a meta-analysis of randomized controlled trials. Int J Clin Pharmacol Ther 59(5):366\u2013371. https:\/\/doi.org\/10.5414\/cp203901","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"4","key":"7078_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1613849","volume":"377","author":"JH Stone","year":"2017","unstructured":"Stone JH, Tuckwell K, Dimonaco S et al (2017) Trial of tocilizumab in giant-cell arteritis. N Engl J Med 377(4):317\u2013328. https:\/\/doi.org\/10.1056\/NEJMoa1613849","journal-title":"N Engl J Med"},{"issue":"4","key":"7078_CR12","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/WNO.0000000000001040","volume":"40","author":"LD Selby","year":"2020","unstructured":"Selby LD, Park-Egan BAM, Winges KM (2020) Temporal artery biopsy in the workup of giant cell arteritis: diagnostic considerations in a Veterans administration cohort. J Neuroophthalmol 40(4):450\u2013456. https:\/\/doi.org\/10.1097\/WNO.0000000000001040. (12)","journal-title":"J Neuroophthalmol"},{"issue":"7","key":"7078_CR13","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1007\/s10067-020-05543-0","volume":"40","author":"SH Chung","year":"2021","unstructured":"Chung SH, Morcos MB, Pollock PS, Ng B (2021) The U.S. Veterans Health Administration national giant cell arteritis (GCA) database cohort: incident ophthalmic complications in biopsy-negative GCA patients. Clin Rheumatol. 40(7):2829\u20132833. https:\/\/doi.org\/10.1007\/s10067-020-05543-0","journal-title":"Clin Rheumatol."},{"issue":"4","key":"7078_CR14","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.survophthal.2016.01.001","volume":"61","author":"L Frohman","year":"2016","unstructured":"Frohman L, Wong AB, Matheos K, Leon-Alvarado LG, Danesh-Meyer HV (2016) New developments in giant cell arteritis. Surv Ophthalmol Jul-Aug 61(4):400\u2013421. https:\/\/doi.org\/10.1016\/j.survophthal.2016.01.001","journal-title":"Surv Ophthalmol Jul-Aug"},{"issue":"4","key":"7078_CR15","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/art.41165","volume":"72","author":"KB Gribbons","year":"2020","unstructured":"Gribbons KB, Ponte C, Craven A et al (2020) Diagnostic assessment strategies and disease subsets in giant cell arteritis: data from an international observational cohort. Arthritis Rheumatol 72(4):667\u2013676. https:\/\/doi.org\/10.1002\/art.41165","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"7078_CR16","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1007\/s00330-018-5311-8","volume":"28","author":"PE Berthod","year":"2018","unstructured":"Berthod PE, Aho-Gl\u00e9l\u00e9 S, Ornetti P et al (2018) CT analysis of the aorta in giant-cell arteritis: a case-control study. Eur Radiol 28(9):3676\u20133684. https:\/\/doi.org\/10.1007\/s00330-018-5311-8","journal-title":"Eur Radiol"},{"issue":"11","key":"7078_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11926-020-00955-y","volume":"22","author":"VS Sch\u00e4fer","year":"2020","unstructured":"Sch\u00e4fer VS, Jin L, Schmidt WA (2020) Imaging for diagnosis, monitoring, and outcome prediction of large vessel vasculitides. Curr Rheumatol Rep 22(11):76. https:\/\/doi.org\/10.1007\/s11926-020-00955-y","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"7078_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00592-019-01385-8","volume":"57","author":"M Finessi","year":"2020","unstructured":"Finessi M, Bisi G, Deandreis D (2020) Hyperglycemia and 18F-FDG PET\/CT, issues and problem solving: a literature review. Acta Diabetol 57(3):253\u2013262. https:\/\/doi.org\/10.1007\/s00592-019-01385-8","journal-title":"Acta Diabetol"},{"key":"7078_CR19","doi-asserted-by":"publisher","first-page":"775","DOI":"10.2147\/OPTH.S243203","volume":"14","author":"R Dammacco","year":"2020","unstructured":"Dammacco R, Alessio G, Giancipoli E et al (2020) Giant cell arteritis: the experience of two collaborative referral centers and an overview of disease pathogenesis and therapeutic advancements. Clin Ophthalmol 14:775\u2013793. https:\/\/doi.org\/10.2147\/OPTH.S243203","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"7078_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/03009742.2021.1889025","volume":"51","author":"A Tomelleri","year":"2022","unstructured":"Tomelleri A, Campochiaro C, Sartorelli S, Farina N, Baldissera E, Dagna L (2022) Presenting features and outcomes of cranial-limited and large-vessel giant cell arteritis: a retrospective cohort study. Scand J Rheumatol 51(1):59\u201366. https:\/\/doi.org\/10.1080\/03009742.2021.1889025","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"7078_CR21","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.semarthrit.2016.11.002","volume":"46","author":"K Tuckwell","year":"2017","unstructured":"Tuckwell K, Collinson N, Dimonaco S et al (2017) Newly diagnosed vs. relapsing giant cell arteritis: baseline data from the GiACTA trial. Semin Arthritis Rheum. 46(5):657\u2013664. https:\/\/doi.org\/10.1016\/j.semarthrit.2016.11.002. (04)","journal-title":"Semin Arthritis Rheum."},{"key":"7078_CR22","doi-asserted-by":"publisher","unstructured":"Sebastian A, Tomelleri A, Kayani A, Prieto-Pena D, Ranasinghe C, Dasgupta B (2020) Probability-based algorithm using ultrasound and additional tests for suspected GCA in a fast-track clinic. RMD Open 6(3).\u00a0https:\/\/doi.org\/10.1136\/rmdopen-2020-001297","DOI":"10.1136\/rmdopen-2020-001297"},{"issue":"2","key":"7078_CR23","doi-asserted-by":"publisher","first-page":"rkac042","DOI":"10.1093\/rap\/rkac042","volume":"6","author":"AR Melville","year":"2022","unstructured":"Melville AR, Donaldson K, Dale J, Ciechomska A (2022) Comment on: Validation of the Southend giant cell arteritis probability score in a Scottish single-centre fast-track pathway Reply. Rheumatol Adv Pract 6(2):rkac042. https:\/\/doi.org\/10.1093\/rap\/rkac042","journal-title":"Rheumatol Adv Pract"},{"issue":"2 Suppl 89","key":"7078_CR24","first-page":"S-103","volume":"33","author":"P Patil","year":"2015","unstructured":"Patil P, Williams M, Maw WW et al (2015) Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study. Clin Exp Rheumatol 33(2 Suppl 89):S-103-6","journal-title":"Clin Exp Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07078-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07078-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07078-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T20:32:15Z","timestamp":1729283535000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07078-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["7078"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07078-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,5]]},"assertion":[{"value":"14 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The proposal was approved by the IRB as a performance quality improvement initiative project. No available ethical approval number.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}